3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Myelodysplastic Syndromes
101
Lymphoma, Non-Hodgkin
94
Leukemia, Lymphocytic, Chronic, B-Cell
94
Hodgkin Disease
88
Multiple Myeloma
82
Leukemia
73
Lymphoma, Mantle-Cell
63
Lymphoma, Follicular
62
Lymphoma
62
Lymphoma, Large B-Cell, Diffuse
59
Myeloproliferative Disorders
55
Lymphoma, B-Cell, Marginal Zone
55
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
54
Burkitt Lymphoma
50
Leukemia, Myelomonocytic, Chronic
48
Congenital Abnormalities
46
Leukemia, Myeloid, Chronic-Phase
45
Lymphoma, Large-Cell, Immunoblastic
42
Leukemia, Myeloid, Accelerated Phase
39
Anemia, Refractory, with Excess of Blasts
36
Hematologic Neoplasms
35
Waldenstrom Macroglobulinemia
34
Primary Myelofibrosis
34
Graft vs Host Disease
34
Blast Crisis
31
Neoplasms, Plasma Cell
30
Recurrence
28
Dendritic Cell Sarcoma, Interdigitating
28
Interventions
Blood Specimen Collection
2
bavituximab
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Steroids
1
Spermine Synthase
1
Sorafenib
1
Prednisone
1
Phlebotomy
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Liquid Biopsy
1
Clinical Protocols
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatitis
×
Mycophenolic Acid
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled